Marolles en Brie, France

Hans Schram

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Disphar International Bv, Nordic Pharma. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans Schram. Retrieved from https://idiyas.com/inventor/hans-schram

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hans Schram

Introduction

Hans Schram is an accomplished inventor based in Marolles en Brie, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory bowel disease (IBD). His innovative work has led to the development of a unique pharmaceutical composition that addresses this medical condition.

Latest Patents

Hans Schram holds a patent for a pharmaceutical composition designed for treating IBD. This stable and/or synergistic composition includes predinisolone metasulfobenzoate (PMSB) or its acceptable salts, preferably prednisolone metasulfobenzoate sodium, along with 5-ASA, derivatives, or pharmaceutically acceptable salts thereof. This formulation is particularly suitable for rectal administration, showcasing his focus on effective treatment methods.

Career Highlights

Throughout his career, Hans has worked with notable companies in the pharmaceutical industry, including Nordic Pharma and Disphar International Bv. His experience in these organizations has allowed him to refine his expertise and contribute to advancements in medical treatments.

Collaborations

Hans Schram has collaborated with talented individuals in his field, including Michael Ikechukwu Ugwoke and Laura Buttafoco. These partnerships have fostered innovation and have been instrumental in the development of his patented compositions.

Conclusion

Hans Schram's contributions to pharmaceutical innovations, particularly in the treatment of IBD, highlight his dedication to improving patient care. His work continues to influence the field and offers hope for effective treatments in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…